Fisetin inhibits IL‐31 production in stimulated human mast cells: Possibilities of fisetin being exploited to treat histamine‐independent pruritus

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Life Science

• Publication date

  2018-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.lfs.2018.03.056PMID 29604269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

  2016cited by this paper
• Fisetin Modulates Antioxidant Enzymes and Inflammatory Factors to Inhibit Aflatoxin-B1 Induced Hepatocellular Carcinoma in Rats

  2015cited by this paper
• SG-HQ2 inhibits mast cell-mediated allergic inflammation through suppression of histamine release and pro-inflammatory cytokines

  2015cited by this paper
• Human Th2 but Not Th9 Cells Release IL-31 in a STAT6/NF-κB–Dependent Way

  2014cited by this paper
• Fisetin Inhibits Hyperglycemia-Induced Proinflammatory Cytokine Production by Epigenetic Mechanisms

  2012cited by this paper
• The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes

  2009cited by this paper
• Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways.

  2008cited by this paper
• Structures and biological functions of IL-31 and IL-31 receptors.

  2008cited by this paper
• Anti-inflammatory activity of fisetin in human mast cells (HMC-1).

  2007cited by this paper
• (—)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes

  2007cited by this paper
• Action of Dracocephalum argunense on mast cell-mediated allergy model.

  2006cited by this paper
• Integrated signalling pathways for mast-cell activation

  2006cited by this paper
• IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.

  2006cited by this paper
• IL-31: a new link between T cells and pruritus in atopic skin inflammation.

  2006cited by this paper
• Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.

  2005cited by this paper
• Vital role of the itch–scratch response in development of spontaneous dermatitis in NC/Nga mice

  2004cited by this paper
• Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

  2004cited by this paper
• Anthocyanins and other flavonoids.

  2004cited by this paper
• Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils.

  2003cited by this paper
• Anthocyanins and other flavonoids.

  2001cited by this paper
• Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study

  2000cited by this paper
• p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.

  2000cited by this paper
• The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

  2000cited by this paper
• Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7.

  1998cited by this paper
• Skin mast cells in polycythaemia vera relationship to the pathogenesis and treatment of pruritus

  1987cited by this paper

• Discovery of compound candidates for the treatment of allergic diseases: integration of DFT analyses, molecular docking, molecular dynamics simulations, and ADMET profiling.

  2026cites this paper
• Effects of Fisetin on Virulence of Actinobacillus Pleuropneumoniae.

  2025cites this paper
• Osthole ameliorates chronic pruritus in 2,4-dichloronitrobenzene-induced atopic dermatitis by inhibiting IL-31 production

  2024cites this paper
• Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation

  2023cites this paper
• Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin.

  2023cites this paper
• The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds

  2023cites this paper
• Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis

  2022cites this paper
• Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS).

  2020cites this paper
• Luteolin suppresses IL-31 production in IL-33-stimulated mast cells through MAPK and NF-κB signaling pathways.

  2020cites this paper
• Commiphora myrrha inhibits itch-associated histamine and IL-31 production in stimulated mast cells.

  2019cites this paper
• Effects of Flavonoids and Its Derivatives on Immune Cell Responses.

  2019influential citation
• Apigenin Inhibits IL-31 Cytokine in Human Mast Cell and Mouse Skin Tissues

  2019influential citation
• Porphyromonas gingivalis induces the production of interleukin‐31 by human mast cells, resulting in dysfunction of the gingival epithelial barrier

  2018cites this paper